The full name of Paclitaxel is Paclitaxel Injection, and the reference price is around 45~70 dollars. Paclitaxel Injection is a prescription drug for first-line and follow-up treatment of progressive ovarian cancer, second-line treatment of AIDS-related Kaposi’s sarcoma, and first-line treatment of non-small cell lung cancer. The reference price of one bottle of the drug is 45-70 dollars, the exact price is different due to the region and hospital where the drug is purchased. Besides this drug is also suitable for the adjuvant treatment of lymph node-positive breast cancer patients after combination chemotherapy with standard adriamycin-containing regimen, metastatic breast cancer with failure of combination chemotherapy or breast cancer that recurs within 6 months of adjuvant chemotherapy. Paclitaxel Injection may cause side effects such as neutropenia, anemia, allergic reactions, infections, and gastrointestinal upset. The drug is contraindicated in the presence of hypersensitivity to paclitaxel or human albumin, during lactation, in pregnant women, and should not be used if the number of neutrophils in the peripheral blood is less than 1500/mm3. Male patients should use contraception during the use of the drug. Paclitaxel injection must be used under the guidance of experienced oncologists.